Want to more details? Please contact us

Want to more details Please contact us

DOTTIKON EXCLUSIVE SYNTHESIS, with its production site in Dottikon (Aargau, Switzerland), specializes on hazardous chemistry and focuses on the exclusive synthesis of fine chemicals for the pharmaceutical and chemical industry worldwide. Our product range includes active pharmaceutical ingredients (APIs) and pharmaceutical intermediates as well as in-house-developed, high-value industrial chemicals.The end application of DOTTIKON ES' pharmaceutical products can be found in medications for, among others, heart disease, asthma, high blood pressure and ulcers. Industrial end products include food additives, cosmetics, electro-chemicals, photo-chemicals, and agricultural chemicals.Our origins traces back to 1913 where at that time our roots as SSF (Swiss Explosive Works) were in the explosives industry. From the 1930's through the 1970's we developed processes for nitration, hydrogenation and oxidation which evolved into our today‘s chemical intermediates business and production using safety-critical chemical reactions. SSF was purchased by Ems-Chemie Holding AG in 1987 and changed name to EMS-DOTTIKON AG in 1990 and finally to DOTTIKON EXCLUSIVE SYNTHESIS AG in 2005. In a spin-off from Ems-Chemie Holding AG transaction and IPO, we were listed under our new parantel company DOTTIKON ES HOLDING AG on March 31, 2005 in the main segment of the SWX Swiss Exchange.